RU2000106746A - LACTIC-ACID BACTERIA STRENGTHENING IMMUNITY - Google Patents

LACTIC-ACID BACTERIA STRENGTHENING IMMUNITY

Info

Publication number
RU2000106746A
RU2000106746A RU2000106746/13A RU2000106746A RU2000106746A RU 2000106746 A RU2000106746 A RU 2000106746A RU 2000106746/13 A RU2000106746/13 A RU 2000106746/13A RU 2000106746 A RU2000106746 A RU 2000106746A RU 2000106746 A RU2000106746 A RU 2000106746A
Authority
RU
Russia
Prior art keywords
rhamnosus
biologically pure
deposited
composition
diluent
Prior art date
Application number
RU2000106746/13A
Other languages
Russian (ru)
Other versions
RU2208632C2 (en
Inventor
Харшарнджит С. ДЖИЛЛ
Джон Б. СМАРТ
Прамод К. ГОПАЛ
Original Assignee
Нью Зиланд Дэйри Борд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8699A external-priority patent/AUPO869997A0/en
Priority claimed from AUPP3225A external-priority patent/AUPP322598A0/en
Application filed by Нью Зиланд Дэйри Борд filed Critical Нью Зиланд Дэйри Борд
Publication of RU2000106746A publication Critical patent/RU2000106746A/en
Application granted granted Critical
Publication of RU2208632C2 publication Critical patent/RU2208632C2/en

Links

Claims (14)

1. Биологически чистая культура либо L. rhamnosus HN001, депонированная 18 августа 1997 в AGAL под номером NM97/09514, либо L. rhamnosus HN067, депонированная 11 февраля 1998 в AGAL под номером NM97/01925.1. A biologically pure culture is either L. rhamnosus HN001, deposited on August 18, 1997 in AGAL under the number NM97 / 09514, or L. rhamnosus HN067, deposited on February 11, 1998 in AGAL under the number NM97 / 01925. 2. Биологически чистая культура L. rhamnosus HN001, депонированная 18 августа 1997 в AGAL под номером NM97/09514. 2. A biologically pure culture of L. rhamnosus HN001, deposited on August 18, 1997 in AGAL under the number NM97 / 09514. 3. Биологически чистая культура L. rhamnosus HN067, депонированная в AGAL под номером NM97/01925. 3. A biologically pure culture of L. rhamnosus HN067 deposited in AGAL under the number NM97 / 01925. 4. Композиция, содержащая биологически чистую культуру любого одного из штаммов L. rhamnosus HN001 по п. 2; L. rhamnosus HN067 по п. 3; B. lactis HN019, депонированного 18 августа 1997 в AGAL под номером NM97/09513; или L. acidophilus HN017, депонированного 18 августа 1997 в AGAL под номером NM97/09515, в иммуностимулирующей концентрации в сочетании с физиологически приемлемым носителем или разбавителем. 4. A composition comprising a biologically pure culture of any one of the strains of L. rhamnosus HN001 according to claim 2; L. rhamnosus HN067 according to claim 3; B. lactis HN019, deposited on August 18, 1997 in AGAL under the number NM97 / 09513; or L. acidophilus HN017, deposited on August 18, 1997 in AGAL under the number NM97 / 09515, in an immunostimulating concentration in combination with a physiologically acceptable carrier or diluent. 5. Композиция по п. 4, содержащая любые два или более из указанных штаммов. 5. The composition according to p. 4, containing any two or more of these strains. 6. Композиция по п. 4 или 5, где указанным физиологически приемлемым наполнителем или разбавителем является пищевой продукт. 6. The composition according to p. 4 or 5, where the specified physiologically acceptable excipient or diluent is a food product. 7. Композиция по п. 6, где указанным пищевым продуктом является один из таких продуктов, как сквашенное молоко, йогурт, сыр, молочный напиток или сухое молоко. 7. The composition according to p. 6, where the specified food product is one of such products as fermented milk, yogurt, cheese, a milk drink or milk powder. 8. Композиция по п. 4 или 5, где указанной композицией является фармацевтическая композиция, а указанным наполнителем или разбавителем является физиологически приемлемый наполнитель или разбавитель. 8. The composition of claim 4 or 5, wherein said composition is a pharmaceutical composition and said excipient or diluent is a physiologically acceptable excipient or diluent. 9. Усиливающие иммунитет физиологически приемлемые биологически чистые штаммы гомологов или мутантов любого из следующих штаммов:
L. acidophilus HN017,
L. rhamnosus HN001,
B. lactis HN019, или
L. rhamnosus HN067.9. Immune enhancing physiologically acceptable biologically pure strains of homologues or mutants of any of the following strains:
L. acidophilus HN017,
L. rhamnosus HN001,
B. lactis HN019, or
L. rhamnosus HN067. 10. Способ усиления природного и приобретенного иммунитета, который предусматривает введение млекопитающему любой из биологически чистых культур по любому из пп. 1-3 и 9 в иммуностимулирующей дозе. 10. A method of enhancing natural and acquired immunity, which involves the introduction to the mammal of any of the biologically pure cultures according to any one of paragraphs. 1-3 and 9 in an immunostimulating dose. 11. Способ по п. 10, где используют биологически чистые культуры двух или трех из вышеупомянутых штаммов. 11. The method according to p. 10, where biologically pure cultures of two or three of the above strains are used. 12. Способ усиления природного и приобретенного иммунитета, предусматривающий введение млекопитающему композиции по любому из пп. 4-8. 12. A method of enhancing natural and acquired immunity, comprising administering to a mammal a composition according to any one of paragraphs. 4-8. 13. Способ по п. 10, где указанным физиологически приемлемым наполнителем иди разбавителем является пищевой продукт. 13. The method of claim 10, wherein said physiologically acceptable excipient or diluent is a food product. 14. Способ по п. 10, где указанным пищевым продуктом является сквашенное молоко, йогурт, сыр, молочный напиток или сухое молоко. 14. The method according to p. 10, where the specified food product is fermented milk, yogurt, cheese, a milk drink or milk powder.
RU2000106746/13A 1997-08-21 1998-08-18 Immunostimulating strain lactobacillus rhamnosus (variants), composition for immunity enhancement (variants), method of immunity enhancement (variants) RU2208632C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPO8699 1997-08-21
AUPO8699A AUPO869997A0 (en) 1997-08-21 1997-08-21 Immuno-enhancing composition
AUPP3225A AUPP322598A0 (en) 1998-04-28 1998-04-28 Immunity-enhancing lactic acid bacteria
AUPP3225 1998-08-28

Publications (2)

Publication Number Publication Date
RU2000106746A true RU2000106746A (en) 2002-02-27
RU2208632C2 RU2208632C2 (en) 2003-07-20

Family

ID=25645584

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000106746/13A RU2208632C2 (en) 1997-08-21 1998-08-18 Immunostimulating strain lactobacillus rhamnosus (variants), composition for immunity enhancement (variants), method of immunity enhancement (variants)

Country Status (22)

Country Link
US (1) US6379663B1 (en)
EP (2) EP2241616B1 (en)
JP (1) JP3694236B2 (en)
KR (1) KR100406344B1 (en)
CN (1) CN1150314C (en)
AU (1) AU727940B2 (en)
BR (1) BR9811332A (en)
DE (1) DE69841826D1 (en)
DK (2) DK1007625T3 (en)
ES (2) ES2349669T3 (en)
GB (1) GB2338245B (en)
HK (1) HK1024719A1 (en)
HU (1) HU228046B1 (en)
ID (1) ID24734A (en)
MY (1) MY116272A (en)
NZ (1) NZ337520A (en)
PL (1) PL195110B1 (en)
RU (1) RU2208632C2 (en)
SK (1) SK283008B6 (en)
TR (1) TR200000451T2 (en)
TW (1) TW587098B (en)
WO (1) WO1999010476A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379663B1 (en) * 1997-08-21 2002-04-30 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1178730B1 (en) * 1999-05-07 2005-03-23 Compagnie Gervais Danone Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
ES2155783B1 (en) * 1999-05-07 2002-05-16 Danone Sa NEW USE OF LACTOBACILLUS CASEI FOR THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF DEPRESSED IMMUNE LEVELS.
ES2155782B1 (en) * 1999-05-07 2002-05-16 Danone Sa USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.
US7125698B2 (en) * 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
HU227086B1 (en) 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
FR2809312B1 (en) * 2000-05-25 2002-07-12 Gervais Danone Sa USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS
TW588109B (en) * 2000-07-29 2004-05-21 Tcell Biotechnology Food Co Lt Lactobacillus rhamnosus strain and uses thereof
EP1311684A4 (en) * 2000-08-08 2005-10-19 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
FI109602B (en) 2001-01-25 2002-09-13 Valio Oy Probiotkombination
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
KR100442205B1 (en) * 2002-02-28 2004-07-30 주식회사 비피도 Bifidobacterium lactis producing β- glucosidase and method for converting isoflavon into isoflavon aglucon using the same
US20040047849A1 (en) * 2002-09-11 2004-03-11 Genmont Biotech Inc. Use of some lactobacillus strains in treating allergy
NZ521836A (en) * 2002-10-08 2005-07-29 New Zealand Dairy Board High pressure treatment to reduce microbial spoilage in cultured dairy foods, cooked meats, vegetables and the like
US20070148147A1 (en) * 2002-12-05 2007-06-28 Veronique Dennin Bacterial composition and its use
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
US6994848B2 (en) * 2004-03-25 2006-02-07 Genmont Biotech Inc. Lactobacillus paracasei strain GM-080 for treating allergy related diseases
ITMI20042189A1 (en) * 2004-11-16 2005-02-16 Anidral Srl COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS USE IN THE PREVENTION OF E-OR IN THE TREATMENT OF PATHOLOGIES AND-OR RESPIRATORY INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY
RU2270248C1 (en) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Bifidobacterium lactis 668 strain for production of fermented milk products, fermented and non-fermented foodstuffs, bioactive supplements, bacterial preparations, and cosmetics
ES2323712T3 (en) * 2005-05-11 2009-07-23 Chr. Hansen A/S LACTIC ACID BACTERIA BREEDS SENSITIVE TO ANTIBIOTICS.
EP2264164A1 (en) 2005-05-11 2010-12-22 Chr. Hansen A/S New antibiotic-sensitive lactic acid bacteria strains
JP2007028920A (en) * 2005-07-22 2007-02-08 Japan Research & Development Association For New Functional Foods Fermented milk and method for producing the same
EP1946760A4 (en) 2005-10-13 2009-07-22 Meiji Seika Kaisha Composition for improving intestinal flora
EP2084276A1 (en) * 2006-11-15 2009-08-05 Chr. Hansen A/S New tetracycline-sensitive bifidobacteria strains
TWI356680B (en) 2007-01-05 2012-01-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
FR2928935B1 (en) * 2008-03-19 2011-05-20 Gervais Danone Sa STRAIN OF LACTOBACILLUS RHAMNOSUS.
CA2737619A1 (en) * 2008-09-19 2010-03-25 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
CA2744778C (en) * 2008-11-28 2019-01-15 University Of Otago Use of lactic acid bacteria to treat or prevent eczema
WO2010103132A1 (en) * 2009-03-10 2010-09-16 Hero España, S.A. Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
WO2011090926A1 (en) 2010-01-19 2011-07-28 Abbott Laboratories Nutritional formulas containing synbiotics
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
WO2012063345A1 (en) * 2010-11-11 2012-05-18 株式会社カザミ Immunopotentiating agent, immunopotentiating composition containing same, and immunopotentiating method
RU2453591C1 (en) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Strain lactobacillus rhamnosus used for making lactic acid bacillus containing products
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
ITRM20130174A1 (en) * 2013-03-22 2014-09-23 Eurospital S P A STRAIN OF LACTOBACILLUS AND ITS USE AS A PROBIOTIC
CA3030809A1 (en) * 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Sialyloligosaccharide product and process
EP4136985A1 (en) 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
RU2769312C2 (en) * 2016-12-22 2022-03-30 Юниверсити Оф Отаго Use of lactic acid bacteria for treating or preventing gestational diabetes mellitus
KR102591869B1 (en) * 2017-06-02 2023-10-19 유니버시티 오브 오타고 Use of lactic acid bacteria to treat or prevent at least one of postpartum depression and postpartum anxiety
KR20230085712A (en) 2021-12-07 2023-06-14 주식회사 에이스브이 Apparatus of disk locking for butterfly valve

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0614862B2 (en) 1987-05-22 1994-03-02 東京田辺製薬株式会社 Bifidobacterium growth promoter
JP2617758B2 (en) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 Antibody production enhancer
JPH0551321A (en) * 1991-08-23 1993-03-02 Yotsuba Nyugyo Kk Immune activating agent
DE69227329T3 (en) 1992-07-06 2003-01-23 Nestle Sa lactic bacteria
AU6244094A (en) 1993-02-24 1994-09-14 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
JP4112021B2 (en) * 1994-02-16 2008-07-02 明治乳業株式会社 Immunostimulant using lactic acid bacteria
JPH092959A (en) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd Immuno-globulin e antibody production suppressant and antiallergic agent
FI102298B1 (en) * 1995-09-07 1998-11-13 Oulutech Oy Method for the determination of lactic acid bacterial species and oligonucleotides suitable for the method
DE69737420T2 (en) * 1996-11-29 2007-11-15 Bio K + International Inc., Montreal MILK ALLOY THE SPECIAL STRAIN OF LACTOBACILLUS ACIDOPHILUS CONTAINS AND USES
US6379663B1 (en) * 1997-08-21 2002-04-30 New Zealand Dairy Board Immunity enhancing lactic acid bacteria

Similar Documents

Publication Publication Date Title
RU2000106746A (en) LACTIC-ACID BACTERIA STRENGTHENING IMMUNITY
CA2099856C (en) Lactic acid bacterium
CA2099855C (en) Antigastritis agent
EP2241616B1 (en) Immunity enhancing lactic acid bacteria
EP1112692B1 (en) Drinks and foods capable of eliminating helicobacter pylori
Kitazawa et al. Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus
CA2313245A1 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
KR101088685B1 (en) A composition having immunoregulating activities comprising lactobacillus pentosus
KR101271379B1 (en) Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation
KR20090024175A (en) Method for culture of lactic acid bacterium having high immunomodulating activity
RU2003112013A (en) LACTIC-ACID BACTERIA REDUCING THE TENDENCY TO MANIFESTATION OF ALLERGIC REACTIONS
CN110484460A (en) One plant has the lactobacillus plantarum for reducing blood fat function and its application
DK0794707T3 (en) Lactic acid ferment and its use in the preparation of anti-diarrheal products
JP4688457B2 (en) Immune enhancing composition
RU97105073A (en) CONSORTIUM OF BIFIDOBACTERIUM BIFIDOBACTERIUM BIFIDUM 791, B. LONGUM B 379 M, B. BREVE 79-119 B. INFANTIS 73-15, B. ADOLESCENTIS D 7513 FOR PREPARATION OF Dairy, non-fermented food
KR100808956B1 (en) Lactic acid bacteria separated from kimchi and exopolysaccharides produced thereby
EA199700075A1 (en) BIFIDOBACTERIUM BIFIDOBACTERIUM BIFIDUM 791 CONSORTIUT, B.LONGUM P379M, B.BREVE 79-119, B.INFANTIS 73-15, B.ADOLESCENTIS G7513 FOR PREPARING ACIDULAR FURNAMOUS, FERTILIZED, FISCAL, FERMENTED, FEDERAL, NON-FERENTED, FISHERENGTH, NON-FERENTED, FROZEN, FEDERAL, FROZEN, FEDERAL, 1515, B.ADOLESCENTIS G7513
JPS5747442A (en) Preparation of milk fermented with bifidus
WO2024071336A1 (en) Acidic bacterial exopolysaccharide having immunopotentiating activity
EP0090617A2 (en) Vaccine for preventing or inhibiting human dental caries induced by cariogenic Streptococcus mutans
RU95110211A (en) Method of preparing fermented-milk product containing living bifidobacteria and lactobacteria
RU99111047A (en) STRAIN BIFIDOBACTERIUM LONGUM IDEAS USED FOR PREPARATION OF ACID-MILK, UNFERMENTED FOOD PRODUCTS, BIOLOGICALLY ACTIVE ADDITIVES AND BACTERIAL PREPARATIONS
Hylmar et al. Obtaining pure dairy cultures with higher dietary and therapeutical properties.
RU93039309A (en) STRAINS BIFIDOBACTERIUM BIFIDUM U-4, USED IN THE COMPOSITION OF BACTERIAL STILLS IN THE PRODUCTION OF FERMENTED Dairy Products
GT199600040A (en) MILK PRODUCT FERMENTED BY THE CULTIVATION IN SYMBIOSIS OF STRAINS OF LACTOBASILLUS CASEIS SRL 431 ATCC 55544 AND LACTOBACILLUS ACIDOPHILUS CRL 73O ATCC 55543.